1st Global Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$375K Buy
11,308
+130
+1% +$4.08K 0.04% 330
2017
Q1
$331K Buy
11,178
+2,064
+23% +$56.3K 0.04% 355
2016
Q4
$226K Sell
9,114
-1,666
-15% -$37.9K 0.03% 455
2016
Q3
$243K Buy
10,780
+818
+8% +$19.2K 0.03% 431
2016
Q2
$237K Sell
9,962
-87
-0.9% -$2.09K 0.03% 418
2016
Q1
$239K Buy
10,049
+2,120
+27% +$51.8K 0.03% 415
2015
Q4
$221K Buy
+7,929
New +$199K 0.03% 389

Other funds holding GMED

1st Global Advisors's GMED Position: Q2 2017 in Review

1st Global Advisors increased its Globus Medical (GMED) stake by 1.2% in Q2 2017, buying an estimated $4.08K and bringing the position to 11,308 shares worth $375K. The position accounts for 0.04% of the portfolio, ranked #330.

1st Global Advisors first reported a position in GMED in Q4 2015 and has held it in 7 quarters since. 244 funds tracked by Wall St. Rank hold GMED as of Q2 2017.

  • 1st Global Advisors held 11,308 shares of Globus Medical worth $375K as of Q2 2017.
  • 1st Global Advisors bought 130 Globus Medical shares in Q2 2017, an estimated $4.08K.
  • Globus Medical made up 0.04% of 1st Global Advisors's portfolio in Q2 2017, its #330 holding.
  • 1st Global Advisors first reported a position in Globus Medical in Q4 2015 and has held it in 7 quarters since.
  • 244 funds tracked by Wall St. Rank held Globus Medical as of Q2 2017.

Based on 1st Global Advisors's 13F filing for Q2 2017, filed 15 Aug 2017.